ArticleCancer immunology, immunotherapy : CII2019

TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma.

Jason Roszik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.